This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Evaluation of the Treatment of Thoracic & Cardiovascular Disease With Biological Therapy: ClinicalCellRegistry.Com

This study is currently recruiting participants.
See Contacts and Locations
Verified September 2016 by Amit N. Patel MD MS, Amit, Patel N, M.D.
Information provided by (Responsible Party):
Amit N. Patel MD MS, Amit, Patel N, M.D. Identifier:
First received: August 12, 2005
Last updated: September 26, 2016
Last verified: September 2016
This is the clinical registry of cell based therapies that is available to researchers around the world. The registry is web based. All researches must provide IRB approval to the coordinating site- University of Utah in order to obtain access to the registry. The are predetermined case report forms for cardiovascular diseases that are currently in clinical trials- including demographics, safety, and possible efficacy end-points. All investigators have access to their own data. The servers are U.S. HIPPA compliant and protected with secure back-up.

Condition Intervention Phase
Cardiovascular System Diseases (& [Cardiac]) Biological: cell therapy Phase 2 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Biological Cell Therapy for the Treatment of Patients With Thoracic & Cardiovascular Disease

Further study details as provided by Amit N. Patel MD MS, Amit, Patel N, M.D.:

Primary Outcome Measures:
  • Safety - MACE - Death, Readmission, Reintervention [ Time Frame: 1 year ]

Estimated Enrollment: 1000
Study Start Date: August 2002
Estimated Study Completion Date: December 2020
Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: cell therapy
Patient receiving active biologic
Biological: cell therapy
autologous or allogeneic cells
Placebo Comparator: control
Patient receiving placebo or standard of care
Biological: cell therapy
autologous or allogeneic cells

Detailed Description:

The clinical cell registry includes data on thoracic and cardiovascular diseases including:

Acute myocardial infarction, Chronic Angina, Heart Failure, Wound Healing including Sternal, Peripheral Arterial Disease, Critical Limb Ischemia, Type 2 Diabetes, COPD, Asthma. Neurological disorders registry is available to specifics sites if requested. Our own biological data at the University of Utah including co-localized data with Society of Thoracic Surgeons also is a part of this program. Cell based therapies that are autologous and allogeneic are included in the registry


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age >=18 years old
  • Approved consent to be enrolled in trial/registry

Exclusion Criteria:

  • Prior malignancy in the 5 years before treatment in this study (other than curatively treated carcinoma in-situ of the cervix or non-melanoma skin cancer)
  • Inability or unwillingness to comply with the treatment protocol, follow-up, research tests, or give consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00130377

Contact: Amit N. Patel, MD, MS
Contact: Amit N Patel, MD,MS

United States, Utah
University of Utah Recruiting
Salt Lake City, Utah, United States, 84132
Contact: Amit Patel, MD MS   
Contact: Kristin Kolsch   
Principal Investigator: Amit Patel, MDMS         
Sponsors and Collaborators
Amit N. Patel MD MS
Principal Investigator: Amit N. Patel, MD, MS University of Utah
  More Information


Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Amit N. Patel MD MS, Amit Patel, Amit, Patel N, M.D. Identifier: NCT00130377     History of Changes
Other Study ID Numbers: 0506137
Study First Received: August 12, 2005
Last Updated: September 26, 2016

Keywords provided by Amit N. Patel MD MS, Amit, Patel N, M.D.:
Stem Cell
cell therapy registry

Additional relevant MeSH terms:
Cardiovascular Diseases processed this record on August 18, 2017